Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03236428
Brief Title: Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

First Submitted : July 11, 2017
First Submitted that Met QC Criteria : July 31, 2017
First Posted : August 1, 2017

Last Update Submitted that Met QC Criteria : February 1, 2021
Last Update Posted : February 2, 2021